ARNI OTC
Arno Therapeutics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -50.0%
1Y: +0.0%
3Y: -95.2%
5Y: -92.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$10M
+47.0% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$10M
+47.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8M
+58.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $0 | -$14M | -$40M | $8M | -$12M |
| Depreciation & Amort. | $12K | $14K | $13K | $13K | $8K |
| Stock-Based Comp. | $822K | $723K | $1M | $5M | $3M |
| Change in Working Capital | -$39K | $777K | $786K | -$2M | -$20K |
| Other Non-Cash Items | -$8M | $6M | $23M | -$29M | -$2M |
| Operating Cash Flow | -$7M | -$9M | -$14M | -$19M | -$10M |
| — Investing Activities — | |||||
| Capital Expenditures | -$23K | $0 | $0 | -$20K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | -$255 | $0 |
| Investing Cash Flow | -$23K | $0 | $0 | -$20K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $15M | $0 | -$255 | $2M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $6K | -$1M | $11M | $0 | -$13K |
| Financing Cash Flow | $6K | $14M | $30M | -$255 | $2M |
| Net Change in Cash | -$7M | $4M | $16M | -$19M | -$8M |
| Cash End of Period | $7M | $11M | $27M | $8M | $67K |
| Free Cash Flow | -$7M | -$9M | -$14M | -$19M | -$10M |